Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers

26 Aug 2016

Abstract excerpt

BACKGROUND: The frequency with which targeted tumor sequencing results will lead to implemented change in care is unclear. Prospective assessment of the feasibility and limitations of using genomic sequencing is critically important. METHODS: A prospective clinical study was conducted on 100 patients with diverse-histology, rare, or poor-prognosis cancers to evaluate the clinical actionability of a Clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27566247
DOI: 10.1634/theoncologist.2016-0049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersPMID 27566247Read ↗

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients.Semantic proximity Read ↗

Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers.Semantic proximity Read ↗

Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersSemantic proximity Read ↗

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.Semantic proximity Read ↗

Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.Semantic proximity Read ↗

Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemSemantic proximity Read ↗

Clinical next generation sequencing to identify actionable aberrations in a phase I program.Semantic proximity Read ↗

Comprehensive Genomic Profiling in Metastatic Solid Tumors: High Actionability But Low Implementation in Real-World PracticeSemantic proximity Read ↗

Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic options.Semantic proximity Read ↗

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.Semantic proximity Read ↗

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.Semantic proximity Read ↗

Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic ArsenalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.